SCHEMBL4299350

SCHEMBL4299350

Cc1cc(C)c2cccc(O)c2n1.Cc1cc(C)c2cccc(O)c2n1.[BeH2]

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.62
TDP1 Q9NUW8 2/20 0.62
KMT2A Q03164 4/20 0.56
OPRK1 P41145 1/20 0.56
METAP2 P50579 1/20 0.53
CYP1A2 P05177 3/20 0.50
CRHR1 P34998 1/20 0.50
PARP1 P09874 2/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SLC6A2 P23975 1/20 0.46
HTT P42858 1/20 0.46
MEN1 O00255 3/20 0.45
MAPT P10636 1/20 0.44
GAA P10253 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2873413 1.00 KDM4E (0.62) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL30587187 1.00 KDM4E (0.62) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL28273809 0.98 KDM4E (0.61) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL29966202 0.98 KDM4E (0.61) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL27551420 0.98 KDM4E (0.61) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL4298175 0.98 KDM4E (0.61) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL4302340 0.98 KDM4E (0.61) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL6037122 0.90 KDM4E (0.53) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL28155200 0.90 KDM4E (0.53) KDM4ETDP1KMT2AOPRK1METAP2
SCHEMBL2430857 0.89 KDM4E (0.51) KDM4ETDP1KMT2AOPRK1METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514158-B2 Coumarin compound KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2009-04-07 US disclosed
US-20070018568-A1 Organic electroluminescent device KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2007-01-25 US disclosed
US-20060228577-A1 Organic electroluminescent device KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2006-10-12 US disclosed
US-20050275341-A1 Coumarin compound KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2005-12-15 US disclosed
EP-1599074-A1 ORGANIC ELECTROLUMINESCENT DEVICE Kabushiki Kaisha Toyota Jidoshokki (JP) 2005-11-23 EP disclosed
EP-1560469-A1 ORGANIC ELECTROLUMINESCENT DEVICE Kabushiki Kaisha Toyota Jidoshokki (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050275341-A1 Coumarin compound XPO1, VKORC1, XPO5 KDM4E 3068/4885TDP1 3317/4885KMT2A 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.